The Effect of High-Intensity Interval Training on Cardiometabolic Risk Factors, Body Composition, and Plasma FABP4 Levels in Sedentary Obese Adults.
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
It is aimed to investigate the responses of Fatty Acid Binding Protein 4 (FABP4), which has been discovered as a novel biomarker of obesity and metabolic diseases, to regular exercise training. The aim of this study is to investigate the effects of high-intensity interval training (HIIT) on cardiometabolic risk factors, body composition, and plasma FABP4 levels in sedentary obese adults.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 35
Healthy Volunteers: t
View:
• Aged between 20 and 35 years,
• BMI between 30 and 35 kg/m²,
• Waist circumference of 90-100 cm for women, 105-110 cm for men,
• Sedentary lifestyle (\<600 MET-min/week),
• Referred by a physician (with a statement confirming no contraindication to exercise).
Locations
Other Locations
Cyprus
Eastern Mediterranean University
RECRUITING
Famagusta
Contact Information
Primary
YAŞAM DİREL, MSc
yasamdirel001@gmail.com
0090 392 6303939
Backup
Mehtap MALKOÇ, Professor.
mehtap.malkoc@emu.edu.tr
0090 392 6303939
Time Frame
Start Date: 2025-03-01
Estimated Completion Date: 2025-09-01
Participants
Target number of participants: 28
Treatments
Experimental: Exercise Group
High-Intensity Interval Training (HIIT)~1-minute interval, 1-minute active recovery 5-minute warm-up, 3-minute cool-down at 60% of peak heart rate.~Weeks 1-2:~Intensity at 85% of peak heart rate during work, active recovery at 60% of peak heart rate, 4 sets of 1-minute work.~Weeks 2-7:~Intensity at 90% of peak heart rate during work, active recovery at 60% of peak heart rate, 6 sets of 1-minute work.~Weeks 8-12:~Intensity at 90% of peak heart rate during work, active recovery at 60% of peak heart rate, 8 sets of 1-minute work.
No_intervention: Control Group
No intervention will be applied to the control group.
Related Therapeutic Areas
Sponsors
Leads: Eastern Mediterranean University